Milestone Scientific Inc. (MLSS) Investor Relations Documents

Milestone Scientific Inc. (MLSS) investor relations documents from the company's IR site: 1 presentation, 39 press releases; latest deck 2025-08-01. Read in-app with summaries. First-party data.

https://www.milestonescientific.com/wp-content/uploads/2025/08/Investor-Presentation-2024.pdf — Milestone Scientific (NYSE: MLSS) is a medical technology company developing computer-controlled injection systems, currently targeting the $2B epidural market.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-14Press releaseMilestone Scientific Reports Financial Results for Second Quarter 2026
2026-08-06Press releaseMilestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
2026-08-04Press releaseMilestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Acce
2026-07-15Press releaseMilestone Scientific Launches First Phase of AI Strategy with Pilot Debut of Milo, an AI-enabled Digital Engagement Plat
2026-07-01Press releaseMilestone Scientific Reports Preliminary 1H 2026 Revenue of ~$5.0M, +9% YoY; Q2 2026 Revenue of ~$2.8M, +21% YoY
2026-06-25Press releaseMilestone Scientific Strengthens Board to Support Next Phase of Growth
2026-05-27Press releaseMilestone Scientific Highlights Growing Clinical Adoption and Expanding Physician Acceptance of CompuFlo® Across Ep
2026-05-07Press releaseMilestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption
2026-04-21Press releaseMilestone Scientific Inc. Completes $2.15 Million Private Placement
2026-03-31Press releaseMilestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025
2026-03-26Press releaseMilestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call
2026-02-23Press releaseMilestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Gro
2026-01-06Press releaseMilestone Scientific Launches The Wand® Ambassador Program to Expand Peer Engagement and Accelerate Market Adoption
2025-11-13Press releaseMilestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
2025-10-14Press releaseMilestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership
2025-10-14Press releaseMilestone Scientific Commits to Regaining NYSE American Compliance Following Notification
2025-09-22Press releaseMilestone Scientific Appoints Dr. Dawood Sayed to Board of Directors to Advance Commercial and Clinical Strategy in Pain
2025-08-13Press releaseMilestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
2025-08-06Press releaseMilestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
2025-08-01Presentationhttps://www.milestonescientific.com/wp-content/uploads/2025/08/Investor-Presentation-2024.pdf
2025-08-01Press releaseMilestone Scientific Appoints Eric C. Hines as Chief Executive Officer
2025-07-17Press releaseMilestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey
2025-05-19Press releaseMilestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
2025-05-15Press releaseMilestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
2025-04-15Press releaseMilestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
2025-04-01Press releaseMilestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
2025-02-04Press releaseMilestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical
2025-01-23Press releaseMilestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Managemen
2024-12-04Press releaseMilestone Scientific to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference on December
2024-11-26Press releaseMilestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFlo® Epidural System
2024-11-14Press releaseMilestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEO
2024-11-14Press releaseMilestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
2024-11-12Press releaseMilestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call
2024-11-01Press releaseMilestone Scientific Expands Commercial Rollout of the CompuFlo® Epidural System with Esteemed Pain Management Phys
2024-10-03Press releaseMilestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at iHeal Pain Center Following Medic
2024-08-15Press releaseMilestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024
2024-08-12Press releaseMilestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference Call
2024-08-07Press releaseMilestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Te
2024-07-30Press releaseMilestone Scientific Secures Key Patent Approvals in the U.S. and Europe
2024-07-23Press releaseMilestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania,

MLSS overview · MLSS earnings · MLSS financials · MLSS KPIs · MLSS ownership · MLSS peers · MLSS filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.